Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;41(7):1553-1560.
doi: 10.55563/clinexprheumatol/3bu1sf. Epub 2023 Apr 6.

Opioid use in children with inflammatory bowel disease-related arthritis

Affiliations

Opioid use in children with inflammatory bowel disease-related arthritis

Atiye O Bilgic Dagci et al. Clin Exp Rheumatol. 2023 Jul.

Abstract

Objectives: Concomitant arthritis may increase risk of chronic opioid use in youngsters with IBD. We aimed to assess trends and clinical features associated with opioid use in children with IBD-related arthritis.

Methods: Adolescents under 18 years of age with IBD-related arthritis, at least 1 year of continuous enrolment, and at least 1 pharmacy claim in the Truven Health MarketScan Claims and Encounter Database were included. Subjects were identified using previously validated algorithms consisting of ICD codes, pharmacy claims and procedure codes. The primary outcome was chronic opioid exposure. Temporal trends in opioid exposure were tested using the Cuzick-Wilcoxon test. The association of chronic opioid use and baseline covariates in the IBD and IBD-arthritis cohorts were examined using multivariable logistic regression models.

Results: 14,943 adolescents with IBD, 480 of whom had arthritis, were included. Chronic opioid use was non-trivial in youngsters with IBD-related arthritis, higher than that of total IBD cohort (12.3% vs. 5%) and remained stable over the years of study. Using multivariable regression, joint pain and arthritis were significantly associated with chronic opioid exposure in young people with IBD. Among IBD-related arthritis patients older age, public insurance, gastrointestinal surgery, hospitalisation and psychiatric comorbidities were significantly associated with chronic opioid use.

Conclusions: Chronic opioid use in adolescents with IBD-related arthritis was higher than that of total IBD cohort but stable over the years of study. Future study is needed to explore ways to optimise non-narcotic pain management strategies and ensuring appropriate use of opioids when necessary.

PubMed Disclaimer

Figures

Fig. 1:
Fig. 1:
Study population selection
Fig 2:
Fig 2:
Chronic opioid exposure in pediatric IBD-related arthritis and IBD cohorts. Point estimates and 95% Confidence Intervals for Yearly Prevalence of Chronic Opioid Exposure Test of trends for IBD arthritis cohort was insignificant p-0.14 but significantly declining trends in the more recent years noted in the entire IBD cohort p=0.001 and IBD patients without arthritis p=0.003

Similar articles

Cited by

References

    1. SCHOLL L, SETH P, KARIISA M, WILSON N, BALDWIN G. Drug and Opioid-Involved Overdose Deaths - United States, 2013–2017. MMWR Morb Mortal Wkly Rep. Jan 4 2018;67(5152):1419–1427. - PMC - PubMed
    1. SRINATH AI, WALTER C, NEWARA MC, SZIGETHY EM. Pain management in patients with inflammatory bowel disease: insights for the clinician. Therap Adv Gastroenterol. Sep 2012;5(5):339–57. - PMC - PubMed
    1. WREN AA, BENSEN R, SCEATS L, et al. Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015. Inflamm Bowel Dis. Sep 15 2018;24(10):2093–2103. - PMC - PubMed
    1. CROSS RK, WILSON KT, BINION DG. Narcotic use in patients with Crohn’s disease. Am J Gastroenterol. Oct 2005;100(10):2225–9. - PubMed
    1. EDWARDS JT, RADFORD-SMITH GL, FLORIN TH. Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics. J Gastroenterol Hepatol. Nov 2001;16(11):1235–8. - PubMed

MeSH terms

Substances